REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Terrace Pharmaceuticals Private Limited (India)

Main Activities: Basic Chemical Manufacturing
Full name: Terrace Pharmaceuticals Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Terrace Pharmaceuticals Private Limited is an unlisted company, incorporated on 11/11/2005. It has its registered office in the State of Punjab, India. Company's corporate identification number (CIN) is U24100PB2005PTC029175 and registration number is 029175. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Plot No. F 67 Phase 7, Industrial Area
Mohali; Punjab; Postal Code: 160055

Contact Details: Purchase the Terrace Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Terrace Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Terrace Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Terrace Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
November 11, 2005
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
26.6%
Company Performance
Financial values in the chart are available after Terrace Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-37.32%▼
Total operating revenue
-37.17%▼
Operating profit (EBIT)
-60.05%▼
EBITDA
-35.41%▼
Net Profit (Loss) for the Period
-48.34%▼
Total assets
-13.12%▼
Total equity
-2.55%▼
Operating Profit Margin (ROS)
-0.49%▼
Net Profit Margin
-0.14%▼
Return on Equity (ROE)
-2.15%▼
Debt to Equity Ratio
-26.16%▼
Quick Ratio
-0.23%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo